EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An evaluation of the quality of Annona muricata leaf products

Wai-Jo Jocelin Chan iD, Joanna E Harnett iD, Alexandra Meroni, Andrew J McLachlan iD, Jane R Hanrahan

Journal of Pharmacy and Pharmacology · 2023

DOI: 10.1093/jpp/rgad066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2023. Verfasst von Wai-Jo Jocelin Chan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Annona, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Annona muricata, also known as graviola, is traditionally used for the treatment of a range of disorders including cancer. Interest in A. muricata use has increased in recent years. This study investigated the quality and safety of a selection of commercially available A. muricata leaf products.

Methods

Seven commercially available products were purchased via online shopping sites. Each product was assessed for quality indicators including weight variation, quantification of the bioactive constituent annonacin, presence of annonaceous acetogenins and contaminants. The samples were evaluated by thin-layer chromatography, high-performance liquid chromatography, liquid chromatography–mass spectroscopy, low-resolution mass spectrometry and nuclear magnetic resonance spectroscopy. Microbial analysis was carried out in accordance with the British Pharmacopoeia. Heavy metals were analysed by inductive coupled plasma mass spectrometry. Key findings Of the seven products analysed, one product contained less than half of the content stated on the label. The labelled dosage recommendation varied between products. There was a high variation in annonacin concentration (1.05–3.09 mg/g) and the presence of annonaceous acetogenins. One of the products was found to have a total aerobic microbial count above the United States Pharmacopoeia limit.

Conclusions

The variation in the indicators of quality and safety of commercially available A. muricata leaf products tested have implications for clinicians and people living with cancer who use these herbal products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnnonaNeoplasmsHumansAcetogeninsPlant LeavesPlant ExtractsFuransLactones

Stichwörter der Autor:innen

Annona muricataacetogeninsannonacinquality controlsafety control

Substanzen

AcetogeninsPlant ExtractsannonacinFuransLactones

Autor:innen und Institutionen

  • Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, Australia.
  • Pharmaceutical Biology, Department Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

ORCID-Profile: Wai-Jo Jocelin Chan, Joanna E Harnett, Andrew J McLachlan

Zitieren

APA

Jocelin Chan, W. J., Harnett, J. E., Meroni, A., McLachlan, A. J., & Hanrahan, J. R. (2023). An evaluation of the quality of Annona muricata leaf products. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad066

Vancouver

Jocelin Chan WJ, Harnett JE, Meroni A, McLachlan AJ, Hanrahan JR. An evaluation of the quality of Annona muricata leaf products. Journal of Pharmacy and Pharmacology. 2023. doi:10.1093/jpp/rgad066

BibTeX
@article{JocelinChan2023,
  author = {Jocelin Chan, Wai-Jo and Harnett, Joanna E and Meroni, Alexandra and McLachlan, Andrew J and Hanrahan, Jane R},
  title = {An evaluation of the quality of Annona muricata leaf products},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2023},
  doi = {10.1093/jpp/rgad066}
}
Kostenlos starten →